La experiencia en Colombia | 14 OCT 16

Síndrome de Guillain-Barré asociado con el virus Zika

Durante el brote epidémico de ZIKA en Colombia se observó el aumento de los casos de síndrome de Guillain–Barré
INDICE:  1. Página 1 | 2. Página 1
Página 1

REFERENCIAS

1. Gatherer D, Kohl A. Zika virus: a previously slow pandemic spreads rapidly through the Americas. J Gen Virol 2016; 97: 269-73.

2. Simpson DI. Zika virus infection in man. Trans R Soc Trop Med Hyg 1964; 58: 335-8.

3. Musso D, Gubler DJ. Zika virus. Clin Microbiol Rev 2016; 29: 487-524.

4. Petersen LR, Jamieson DJ, Powers AM, Honein MA. Zika virus. N Engl J Med 2016;  374: 1552-63.

5. Cao-Lormeau VM, Blake A, Mons S, et al. Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 2016; 387: 1531-9.

6. Oehler E, Watrin L, Larre P, et al. Zika virus infection complicated by Guillain- Barre syndrome — case report, French Polynesia, December 2013. Euro Surveill 2014; 19.

7. Zika virus microcephaly and Guillain-Barré syndrome: situation report, 4 March 2016. Geneva: World Health Organization, 2016 (http://apps .who .int/ iris/bitstream/ 10665/ 204526/ 2/ zikasitrep_4Mar2016_eng .pdf).

8. MinSalud confirma primeros nueve casos de Zika en Colombia. Bogota: Ministerio de Salud Colombia, October 16, 2015 (https:/ / www .minsalud .gov .co/Paginas/ Confirmados-primeros-casos-de -virus-del-zika-en-Colombia .aspx).

9. Hadden RD, Cornblath DR, Hughes RA, et al. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Ann Neurol 1998; 44: 780-8.

10. Ho TW, Mishu B, Li CY, et al. Guillain-Barré syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies.Brain 1995; 118: 597-605.

11. Sejvar JJ, Kohl KS, Gidudu J, et al.Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2011; 29: 599-612.

12. Zika: case definitions. Washington, DC: Pan American Health Organization, April 1, 2016 (http://www .paho .org/ hq/ index .php?option=com_content&view=article&id=11117&itemid=41532&lang=en).

13. Lanciotti RS, Kosoy OL, Laven JJ, et al.Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 2008; 14: 1232-9.

14. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase polymerase chain reaction. J Clin Microbiol 1992; 30: 545-51.

15. Osorio L, Ramirez M, Bonelo A, Villar LA, Parra B. Comparison of the diagnostic accuracy of commercial NS1-based diagnostic tests for early dengue infection. Virol J 2010; 7: 361.

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024